While #Fenbendazole  shares similarities with other drugs that target microtubules or exploit tumor hypoxia, the findings of this study do not support its further development as an anticancer agent. Its minimal impact on tumor growth and resistance to radiation suggest that, in its current form, the drug is unlikely to provide meaningful clinical benefits. Nevertheless, the study highlights the potential for related compounds, particularly those with improved absorption or enhanced activity against hypoxic cells, to be investigated as candidates for cancer therapy./43
#Fenbendazole